BILIARY TRACT NEOPLASMS
Clinical trials for BILIARY TRACT NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new BILIARY TRACT NEOPLASMS trials appear
Sign up with your email to follow new studies for BILIARY TRACT NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug targets hard-to-treat cancers in early trial
Disease control Not yet recruitingThis study tests a drug called Trastuzumab Rezetecan in 15 adults with advanced solid tumors that have the HER2 protein. The goal is to see if the drug can shrink tumors. Participants get the drug by IV every 3 weeks. This is for people whose cancer has worsened after other treat…
Matched conditions: BILIARY TRACT NEOPLASMS
Phase: PHASE2 • Sponsor: Haihua Yuan • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Immunotherapy plus chemo aims to fight bile duct cancer
Disease control Not yet recruitingThis Phase 2 trial tests whether adding the immunotherapy drug envafolimab to standard chemotherapy (gemcitabine plus cisplatin) helps people with advanced biliary tract cancers live longer without their cancer growing. About 126 adults who have not had prior treatment for advanc…
Matched conditions: BILIARY TRACT NEOPLASMS
Phase: PHASE2 • Sponsor: 3D Medicines (Sichuan) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New hope for bile duct cancer: maintenance therapy trial launches
Disease control Not yet recruitingThis study is for people with advanced biliary tract cancer whose disease is stable after initial chemotherapy plus immunotherapy. It compares four different maintenance treatments: immunotherapy alone or combined with lenvatinib, venadaparib, or interleukin-2. The goal is to fin…
Matched conditions: BILIARY TRACT NEOPLASMS
Phase: PHASE1, PHASE2 • Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New drug aims to shield cancer patients from chemo side effects
Disease control Not yet recruitingThis phase 2 trial tests whether the drug trilaciclib can protect bone marrow in 96 people with advanced bile duct or pancreatic cancer before they receive chemotherapy. The goal is to reduce serious side effects like low white blood cell counts, which can lead to infections. Par…
Matched conditions: BILIARY TRACT NEOPLASMS
Phase: PHASE2 • Sponsor: The Second Affiliated Hospital of Shandong First Medical University • Aim: Disease control
Last updated Jun 26, 2026 14:31 UTC
-
Can a meditation app ease pain and anxiety after pancreatic surgery?
Symptom relief Not yet recruitingThis study tests whether scheduled meditation using the Headspace app can improve recovery after pancreatectomy (surgery to remove part of the pancreas). Seventy patients will be asked to meditate regularly before and after surgery, and researchers will track pain, anxiety, sleep…
Matched conditions: BILIARY TRACT NEOPLASMS
Phase: NA • Sponsor: City of Hope Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
Tube Tug-of-War: keeping or removing drain during pancreatic surgery may cut complications
Knowledge-focused Not yet recruitingThis trial looks at whether keeping or removing a drainage tube (PTCD catheter) during pancreatic surgery leads to fewer complications. About 100 patients with jaundice from tumors will be randomly assigned to one of two groups. The main goal is to see which approach reduces seri…
Matched conditions: BILIARY TRACT NEOPLASMS
Phase: NA • Sponsor: Xu'an Wang • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC